News

Dr. Daniel Greenstein Takes the Helm at Baker Tilly Advisory

Dr. Daniel Greenstein Takes the Helm at Baker Tilly Advisory

Baker Tilly Welcomes Dr. Daniel Greenstein to Its Higher Education Advisory Team

Baker Tilly, a leading advisory, tax, and assurance firm, is welcoming Dr. Daniel Greenstein to its higher education advisory practice. He’ll be stepping into the role soon, opening a new chapter for both him and the firm. The timing matters: higher education in the United States is confronting complex, interlocking challenges, and institutions are looking for grounded, practical guidance.

Why Dr. Greenstein’s leadership matters

Most recently, Dr. Greenstein served as Chancellor of Pennsylvania’s State System of Higher Education (PASSHE). In that post, he championed a set of initiatives designed to refresh and rework the state’s public university system so it could better serve students and communities. The system supported more than 80,000 students pursuing their degrees, and under his leadership it placed equity at the center—expanding pathways for underserved communities and working to narrow gaps in educational attainment. The throughline in his approach was simple: keep students at the center, and align decisions with that north star.

A commitment to strengthening higher education

As he transitions to Baker Tilly, Dr. Greenstein has expressed real enthusiasm for continuing his work to strengthen higher education at scale. He’s clear-eyed about the moment: solving the sector’s biggest problems calls for solutions that are both innovative and bold, and for teams that can move ideas into action. He’s joining Baker Tilly to do exactly that—bringing experience, perspective, and a focus on outcomes to a broader set of colleges and universities.

Strategic priorities at Baker Tilly

At Baker Tilly, Dr. Greenstein plans to lead projects designed for the fast-changing needs of higher education institutions. His priorities are straightforward and ambitious: improve student outcomes and help institutions achieve long-term sustainability. To get there, he’ll concentrate on refining operations, aligning educational models with what the market demands, and using technology and data analytics more effectively. The goal is to help institutions make better decisions today while preparing for what’s next, so they can serve students well and remain resilient over time.

How his experience fits Baker Tilly’s vision

Baker Tilly’s vision is to help clients realize their goals, and Dr. Greenstein’s experience strengthens that mission. Vicki Hellenbrand, Managing Principal of Government and Public Services at Baker Tilly, has noted that his commitment to advancing equity in education aligns closely with the firm’s objectives. It’s a natural match: a firm focused on results and a leader who’s spent his career pursuing better outcomes for students and institutions alike.

A record of results

Before leading PASSHE, Dr. Greenstein was a senior executive at the Bill and Melinda Gates Foundation, where he drove initiatives aimed at increasing educational attainment across the country. Those efforts contributed to more degrees earned and expanded opportunities for economic mobility, especially for students from diverse backgrounds. Earlier, he served as Vice Provost for Academic Planning and Programs for the University of California system. Across these roles, the pattern holds: targeted initiatives, clear goals, and a steady focus on improving educational outcomes.

About Baker Tilly

Baker Tilly is recognized as a premier advisory, tax, and assurance organization, serving clients in the United States and around the world. Through an extensive network of independent members in 141 territories, the firm brings the expertise of approximately 43,000 professionals. Together, they generate a combined revenue of $5.2 billion. That scale supports a simple promise: help clients navigate complexity and deliver professional services that create tangible value.

Find out more

If you’d like to explore Baker Tilly’s higher education advisory services, more information is available on the firm’s website. The team provides comprehensive advisory support with an emphasis on practical, impactful change for institutions, their students, and the communities they serve.

Frequently Asked Questions

Who is Dr. Daniel Greenstein?

Dr. Daniel Greenstein is a seasoned higher education leader who most recently served as Chancellor of Pennsylvania’s State System of Higher Education. His work has focused on strengthening public institutions, improving student success, and advancing equity.

What is Baker Tilly?

Baker Tilly is a global advisory, tax, and assurance firm. It serves clients across the United States and internationally, bringing together deep industry knowledge and professional services to help organizations meet their goals.

What will Dr. Greenstein focus on at Baker Tilly?

He will lead projects that help colleges and universities improve student outcomes and build long-term institutional sustainability. His approach includes optimizing operations, aligning education models with market needs, and leveraging technology and data analytics.

How does Baker Tilly support higher education?

The firm offers advisory services tailored to the complex needs of higher education. Its teams work with institutions to tackle pressing challenges, make informed decisions, and implement changes that benefit students and the institution as a whole.

Why is his addition significant?

Dr. Greenstein brings experience from leading a statewide public university system and from senior roles focused on boosting educational attainment. His track record in equity and outcomes aligns closely with Baker Tilly’s mission and strengthens its higher education advisory practice.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 244

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 268

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 191

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 233

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Rights for Paragon 28, Inc. Shareholders: Essential Info

Updated Category News Views 85

Legal Rights for Shareholders of Paragon 28, Inc. Attention shareholders of Paragon 28, Inc. (NYSE: FNA): As developments unfold regarding potential legal action related to financial misconduct, it is crucial for you to understand your rights and options. If you purchased shares of FNA during the specified class period, there are steps you can take to ensure that your...

Continue Reading
Embecta Set for Upcoming Fiscal Quarter Conference Call

Updated Category News Views 305

Embecta Corp. Financial Results Conference Call Embecta Corp. (“embecta”) (Nasdaq: EMBC), a prominent global player in diabetes care, is gearing up to present its financial performance for the fiscal second quarter of 2025. This pivotal event will offer stakeholders a comprehensive look at the company's recent achievements and ongoing operational updates. Conference...

Continue Reading
Investors Alert: HealthEquity, Inc. under Investigation Now!

Updated Category News Views 153

Investigation of HealthEquity, Inc. Pomerantz LLP is currently investigating claims on behalf of investors from HealthEquity, Inc. (NASDAQ: HQY). Investors who believe they may have been impacted are encouraged to reach out for further information. This investigation focuses on whether HealthEquity and certain officers or directors have been involved in securities fraud...

Continue Reading
Enhancing Access to Mental Health and Dermatology Services

Updated Category News Views 259

Health-E Commerce Teams Up with Sesame for Better Care The new collaboration significantly shortens waiting periods for those seeking mental health and dermatology consultations, delivering substantial savings for millions enrolled in tax-advantaged FSAs and HSAs. Accessible Mental Health and Dermatology Solutions Health-E Commerce, the parent organization behind FSA...

Continue Reading
Massive Gains Expected for Hyperliquid Amid Altcoin Buzz

Updated Category News Views 281

Hyperliquid's Promising Future in the Crypto Market As the cryptocurrency landscape continues to evolve, analysts are closely observing the potential of various altcoins. Recently, a well-known crypto analyst, Sherpa, has highlighted the altcoin Hyperliquid, predicting an exciting journey ahead for its utility token, HYPE. Analyst’s Predictions for Hyperliquid Expected...

Continue Reading